Sector Expert: Ross Silver

Sylva International , Vista Partners

Image: Ross Silver

Ross Silver has been advising, researching and investing in public companies across all industries throughout his career with a significant emphasis on biotechnology, technology and natural resources. Prior to founding Vista Partners LLC in 2005, Silver served as a research analyst for a San Francisco-based hedge fund. From 2000 to 2003, Silver served as a research associate covering consumer discretionary and consumer staple companies at Dresdner RCM (now Allianz). Prior to joining Dresdner RCM, Silver was a member of CIBC's Technology, Media, and Telecom Investment Banking group, where he assisted with equity and debt offerings. Silver holds a bachelor's degree in business economics from the University of California, Santa Barbara. He has served as a consultant for government agencies including the National Institutes of Health (NIH). He holds a Series 65 Securities license.



Recent Quotes

"SNGX's current valuation doesn't currently reflect the potential upside."

— Ross Silver, Vista Partners (4/19/16)
more >

"SNGX boasts a diverse pipeline with eight prospective drug candidates."

— Ross Silver, Vista Partners (12/18/15)
more >

"SNGX is an exciting company; it is rare to find a micro cap with such a diverse and broad clinical pipeline."

The Life Sciences Report Interview with Ross Silver (5/20/15)
more >

"INO has had a number of successes clinically and marquee collaborations that have led to its market cap being what it is today."

The Life Sciences Report Interview with Ross Silver (5/20/15)
more >

"The science behind SNGX's therapies continues to be validated by significant, important and influential entities."

— Ross Silver, Vista Partners (2/12/15)
more >

"CYD has potential to delineate significant resources at El Barqueño over the next 12 months."

— Ross Silver, Vista Partners (4/24/14)
more >

"We initiate coverage on URZ; its offtake agreements are for prices 50% higher than the current price of uranium."

— Ross Silver, Vista Partners (3/26/14)
more >

"We are initiating coverage on SNGX; we estimate its NPV to be $138M."

— Ross Silver, Vista Partners (3/18/14)
more >



Due to permission requirements, not all quotes are shown.